Pharmacokinetics and Safety of Erenumab after a Single Subcutaneous Injection Dose in Healthy Chinese Subjects-Reference-Cited by-同舟云学术

Pharmacokinetics and Safety of Erenumab after a Single Subcutaneous Injection Dose in Healthy Chinese Subjects

Published:2022-06-21 Issue:7 Volume:42 Page:623-630
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clin Drug Investig

Author:

Shen Qi,Jin Ying^ORCID,Di Xiangjie^ORCID,Hu Chao,Liu Runhan^ORCID,Wang Ying,Qi Xiaohui,Wang Yongsheng,Wang Zhenlei^ORCID

Funder

Youth Program of National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40261-022-01171-5.pdf

Reference30 articles.

1. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789–858.

2. Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17:954–76.

3. Ashina M, Katsarava Z, Do TP, et al. Migraine: epidemiology and systems of care. Lancet. 2021;397:1485–95.

4. Saylor D, Steiner TJ. The global burden of headache. Semin Neurol. 2018;38:182–90.

5. Ailani J, Lipton RB, Goadsby PJ, et al. Atogepant for the preventive treatment of migraine. N Engl J Med. 2021;385:695–706.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-calcitonin Gene-Related Peptide Monoclonal Antibodies in Migraine: Focus on Clinical Pharmacokinetics;European Journal of Drug Metabolism and Pharmacokinetics;2024-03-10

2. Correction: Pharmacokinetics and Safety of Erenumab after a Single Subcutaneous Injection Dose in Healthy Chinese Subjects;Clinical Drug Investigation;2023-11-22

3. Pharmacokinetics and Safety of Eptinezumab in Healthy Chinese Participants: A Randomized Clinical Trial;Clinical Drug Investigation;2023-11

4. Pharmacological characterisation of erenumab, Aimovig, at two calcitonin gene‐related peptide responsive receptors;British Journal of Pharmacology;2023-09-14